CPHI India has returned with momentum this year, underscoring India’s rapid rise in the global pharmaceutical landscape. With record-breaking attendance and a surge in exhibitor numbers, the event highlights India’s potential as a hub for pharmaceutical innovation, supply chain modernization, and international partnerships. Here’s how CPHI India is shaping the future of the pharmaceutical sector in India.
India’s Growth in Global Pharma: A Top-Ranked Nation
India continues to secure its position as a top player in the global pharma industry. According to the latest CPHI Annual Survey 2024, India ranks as the number one growth nation for 2025. This achievement reflects the country’s robust capabilities and potential for growth, driven by advancements in Contract Development and Manufacturing Organizations (CDMO) and Contract Research Organizations (CRO). This year, CPHI India will host over 2,000 exhibitors, marking the event’s largest edition yet and underscoring India’s prominence in global pharma.
Why CPHI India is Attracting Record Attendance
As the largest pharma event in India, CPHI India & PMEC is expected to host over 50,000 executives from more than 150 countries. This year’s event brings together an impressive array of suppliers and advanced equipment providers, showcasing India’s expanding pharmaceutical ecosystem. According to Olga Ponomareva-Stepnaya, Brand Manager of CPHI & PMEC India, the event’s record attendance is a testament to India’s ongoing transformation in pharma manufacturing and supply chain diversity.
New Initiatives at CPHI India to Drive Collaboration
To foster international partnerships, CPHI India has introduced new initiatives like the Connections Programme. This program is designed to connect international buyers with key exhibitors, facilitating high-value deals and collaborations. Feedback from previous events revealed that attendees often struggled to meet the right suppliers at such a large event. The Connections Programme addresses this by offering dedicated support for strategic connections.
Spotlight on Startups and Emerging Enterprises
Reflecting the industry’s trend towards innovation, CPHI India will dedicate space for emerging startups in the pharmaceutical sector. This initiative aligns with Informa’s commitment to supporting innovation across all CPHI events globally, encouraging startups to bring fresh ideas and technological advancements to the Indian pharmaceutical landscape. By providing a platform for these new enterprises, CPHI India is helping to foster a more dynamic, future-ready pharma ecosystem in India.
Focus on Sustainability and Green Chemistry
CPHI India will host two conference streams to address key industry challenges and opportunities: the Pharma Manufacturing Conclave and the Pharma Sustainability Conclave. These sessions cover crucial topics like biosimilar supply chains, next-generation manufacturing infrastructure, and sustainable practices. With a strong emphasis on green chemistry and updated pharmaceutical regulations, these sessions will provide insights into building a more sustainable pharma industry in India.
Honoring Excellence with the India Pharma Awards 2024
Concluding the event, the India Pharma Awards 2024 will recognize outstanding contributions across 13 categories, celebrating industry leaders, innovators, and visionaries. This year marks the 11th edition of the awards, which will take place on November 28, 2024, at the Expo Centre. The awards underscore India’s commitment to excellence in pharmaceutical advancements and acknowledge the individuals and companies shaping the industry’s future.
Conclusion: CPHI India as a Catalyst for Industry Growth
With its comprehensive showcase of suppliers, new initiatives for collaboration, and dedicated sessions on sustainability, CPHI India has positioned itself as a catalyst for growth in the Indian pharmaceutical sector. The event serves as a testament to India’s capabilities and potential, attracting global attention and strengthening its role as a leading pharmaceutical hub. As CPHI India continues to expand, it will undoubtedly play a critical role in shaping the future of pharmaceuticals both in India and globally.
